title: Patterns of LHbetacf among women in health and disease.
abstract: Urine based gonadotropin assays provide a practical means of analyzing hormone secretion patterns. While research protocols have revealed pulsatile patterns of gonadotropins such as LH in the blood, these assays are of limited clinical use since daily venipuncture sampling is not feasible outside of a research environment. However, collection of several urine samples provides a method to achieve the same visualization of gonadotropin patterns in patients using a convenient and generally applicable technique based on analysis of the highly stable hLHbetacf for monitoring LH and hCGbetacf for monitoring pituitary hCG. We demonstrated that two different sampling techniques for analyzing these gonadotropin metabolites yielded the same information on their excretory patterns, either sampling of spot urines or collecting first morning void urines for several days. Next, we studied the core excretory patterns in several populations: menstruating and postmenopausal women from the general population, and two populations of women from a fertility center, one of which had polycystic ovaries (PCO). The PCO population was also subdivided into those with and without insulin resistance (IR). It was found that our hLHbetacf assay did not measure the form of the LH core (v-hLHbetacf) produced in subjects who were homozygous for a variant form of LH (v-LH). None of our patients tested were homozygous for the variant form of LH. It was also found that in most non-PCO (NPCO) patients, the hLHbetacf peak lasted for 7-9 days while among the PCO patients this peak frequently lasted for less than 7 days and an erratic pattern tended to appear. The overall differences in patterns between the PCO and NPCO patients were confirmed by spectral statistical methods. The prevalence of certain characteristic hLHbetacf patterns may be higher among women with PCO with a more severe clinical presentation. Use of urinary analysis of gonadotropin metabolites, especially hLHbetacf, may supplement subjective ultrasound studies with more sensitive biochemical measurements.
authors.affiliation: Department of Ob/Gyn of Columbia College of Physicians & Surgeons, New York, United States. birken@comcast.net
authors.forename: Steven
authors.initials: S
authors.lastname: Birken
authors.forename: Ruth
authors.initials: R
authors.lastname: McChesney
authors.forename: Oksana
authors.initials: O
authors.lastname: Yershova
authors.forename: John
authors.initials: J
authors.lastname: Gaughan
authors.forename: Kim
authors.initials: K
authors.lastname: Pettersson
authors.forename: Geoff
authors.initials: G
authors.lastname: Rechenberg
authors.forename: Chung H
authors.initials: CH
authors.lastname: Wu
authors.forename: George
authors.initials: G
authors.lastname: Taliadouros
mesh_terms: D000328:Adult; D019540:Area Under Curve; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000652:urine; D005260:Female; D005298:Fertility; D006262:Health; D006801:Humans; D007118:Immunoassay; D037101:Luteinizing Hormone, beta Subunit / Q000276:immunology / Q000652:urine*; D008597:Menstrual Cycle / Q000502:physiology; D009154:Mutation / Q000235:genetics; D011085:Polycystic Ovary Syndrome / Q000503:physiopathology / Q000652:urine*; D017698:Postmenopause / Q000502:physiology
chemical_list: D018997:Chorionic Gonadotropin, beta Subunit, Human; D037101:Luteinizing Hormone, beta Subunit